Group One Trading
ARKG icon

Group One Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Group One Trading’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Sell
444,800
-80,600
-15% -$2.36M 0.02% 741
2025
Q4 		$15.2M Buy
525,400
+225,000
+75% +$6.75M 0.03% 696
2025
Q3 		$8.34M Buy
300,400
+61,700
+26% +$1.56M 0.01% 1048
2025
Q2 		$5.81M Sell
238,700
-138,400
-37% -$3.03M 0.01% 1215
2025
Q1 		$7.83M Sell
377,100
-153,300
-29% -$3.85M 0.02% 769
2024
Q4 		$12.5M Buy
+530,400
New +$13.1M 0.03% 581

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Group One Trading's ARKG Position: Q1 2026 in Review

Group One Trading increased its ARK Genomic Revolution ETF (ARKG) stake by 168% in Q1 2026, buying an estimated $842K and bringing the position to 45,861 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2532.

Group One Trading first reported a position in ARKG in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.51M in Q3 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Group One Trading held 45,861 shares of ARK Genomic Revolution ETF worth $1.21M as of Q1 2026.
  • Group One Trading bought 28,765 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $842K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2532 holding.
  • Group One Trading first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 5 quarters since.
  • Group One Trading's ARK Genomic Revolution ETF position peaked at $3.51M in Q3 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.